Bottom line
Is PCVAX a good fund? The bottom line
PCVAX is a share class of Virtus NFJ Small-Cap Value Fund, an actively managed small-cap mutual fund from Virtus.
It charges 1.17% — about $117 a year on every $10,000 invested, more expensive than 67% of small-cap funds we track.
It returned −4.5% over one year, +5.3% a year over five years, +5.2% a year over ten (as of Dec 31, 2025, per its prospectus).
With $259 million in net assets and 78 holdings, its largest position is Victoria's Secret & Company (3.6%) and the top 10 make up 22.8% of the portfolio.
This share class carries a front-end sales charge of up to 5.5%; a no-load class or ETF alternative can avoid it.
What to watch
- Front-end sales load up to 5.5%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What PCVAX invests in
The fund seeks long-term growth of capital and income.
Under normal circumstances, the fund invests at least 80% of its net assets (plus borrowings made for investment purposes) in common stocks and other equity securities of value companies with smaller market capitalizations. Equity securities represent an ownership interest, or the right to acquire an ownership interest, in an issuer. Equity securities include common stocks (including depositary receipts evidencing ownership of common stock), preferred stocks and other preferred securities, convertible securities, rights and warrants, and other securities, such as hybrid securities and trust preferred securities, believed to have equity-like characteristics. As of the date of this prospectus, the funds subadviser considers value companies for this purpose to be those companies whose securities the portfolio managers believe have attractive valuation and fundamental strength and…
From the fund's prospectus (filed Oct 22, 2026).
PCVAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| PCVAX | −4.5% | +5.3% | +5.2% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What PCVAX costs
On a $10,000 investment, PCVAX's 1.17% expense ratio costs about $117 a year. The prospectus estimates $1,932 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
PCVAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Victoria's Secret & Company VSCO | 3.55% |
| 2 | Sanmina Corp SANM | 2.36% |
| 3 | Exelixis Inc EXEL | 2.29% |
| 4 | Littelfuse Inc LFUS | 2.26% |
| 5 | Enterprise Financial Services Corp EFSC | 2.14% |
| 6 | Radian Group Inc RDN | 2.09% |
| 7 | Community Financial System Inc CBU | 2.06% |
| 8 | Glacier Bancorp Inc GBCI | 2.05% |
| 9 | Hf Sinclair Corp DINO | 2.04% |
| 10 | Indivior Pharmaceuticals Inc INDV | 2.02% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 22.8% of the fund. See all top 25 holdings and asset mix →